Autism Spectrum Disorders - Adult Study
Sexual Well Being of High Functioning Adults with Autism Spectrum Disorders
Protocol ID
07.04.051
Protocol Description
The purpose of this study is to better understand sexuality and relationships of adults living in the community with self-reported high-functioning autism spectrum disorders (ASDs).
You may qualify for participation in this study if:
1) You have reported that you have a pervasive developmental disorder (such as Autism, Asperger Syndrome, or Pervasive Developmental Disorder Not Otherwise Specified).
2) You are between 21 and 75 years old.
3) You are verbally conversant and consider yourself to have a verbal IQ in the low average range to the above average range.
Eligibility Criteria
Adults with self-reported high-functioning autism spectrum disorders (ASDs)
Primary Investigator(s)
- Shana Nichols, PhD
Contact Information
Last Update
April 2, 2010How did I get to this page?
Related Information
- News Room
-
Clinical Trials
- Systemic Lupus Erythematosus - Classification and Criteria (ARoSE) (07.08.049)
- Systemic Lupus Registry (07-053)
- Systemic Lupus Erythematosus - Vitamin D3 Study (08-109)
- Systemic Lupus Erythematosus - Gene Study (SAGE) (08-205)
- Pulmonary Artery Hypertension - Biomarker Study (07-030)
- Bipolar Disorder - ECT Follow-up Study (04.08.132T)
- Bipolar Disorder - Neurocognitive Study (04.04.105)
- Cystic Fibrosis Patient Registry (02.08.156)
- Systemic Lupus Erythematosus - Pediatric Atherosclerosis Prevention Study (03.10.074T)
- System Lupus Erythematosus - Study of 3.3-Diidolymethane (06.02.107T)
- Rituximab in SLE: Effects of Immune Reconstitution on Treatment Response (06.08.094T)
- Cystic Fibrosis Patient Registry (Pediatrics) (02.08.171)
- Acute Coronary Syndrome Study (06-099T)
- Clinical Correlates of Memory Impairment (03.08.160)
- Alzheimer's Disease - Memantine Study (06.02.108T)
- Autism Genetic Study (02-098T)
- Normal Control Registry for Current and Future Research (04-007/G)
- Pitch Recognition in Autistic Spectrum Disorders (04-053)
- Research Recruitment Screening Database (05.08.167T)
- Systemic Lupus Erythematosus - PET/MRI Study (07-012)
- Lupus Nephritis - Clinical Trial (08-197)
- Systemic Lupus Erythematosus - Antibody Study (07-081)
- Cognitive Enhancement in Bipolar Disorder (05-069)
- Schizophrenia - Relapse Prevention Study (05.04.063)
- Autism - Parent Education Study (06-069)
- Bipolar Susceptibility Study (08-132)
- Brain Networks in Parkinson's Disease (04-113T)
- Schizophrenia - Clinical Trial (05.04.086)
- National Marrow Donor Program's Research Sample Repository (03.10.116)
- National Marrow Donor Program Research Database (03.10.117)
- Smoking Cessation - Lozenge vs. Patch (06-030)
- Tissue Banking - Laryngeal and Tracheal Disease (03.02.080)
- Bipolar Disorder - White Matter Integrity Study (02.08.187)
- Stenting and Angioplasty Post-Marketing Study (06-02-281)
- Systemic Lupus Erythematosus - Clinical Trial (07-02-190)
- CF - Expanded Access Study (07-02-201)
- Systemic Lupus Erythematosus - Clinical Trial (07-02-81)
- Focal Segmental Glomerulosclerosis Study (07-10-238)
- Systemic Lupus Erythematosus - Clinical Trial (08-02-145)
- HIV - Clinical Trial (08-02-160)
- Asthma - Clinical Trial (08-02-188)
- Systemic Lupus Erythematosus - Clinical Trial (08-02-207)
- Cystitis-Painful Bladder Study - (08-269)
- Pelvic Pain Study - (08-274)
- Prediction of Relapse in Schizophrenia - (08-278)
- Schizophrenia - Clinical Trial (08-296)
- Autism - Genetic Study (09-036)
- Systemic Lupus Erythematosus - Clinical Trial (09-02-112)
- Systemic Lupus Erythematosus - Clinical Trial (09-02-133)
- Cystic Fibrosis - Clinical Trial (09-02-147)
- Cystic Fibrosis - Clinical Trial (09-10-102)
- Systemic Lupus Erythematosus Registry (09-104)
- Bipolar Disorder - Mindfulness Training Study (10-013B)
- Vest Prevention of Early Sudden Death Trial (VEST) and Prediction of ICD Therapies Study (PREDICTS) (09-056)
- Systemic Lupus Erythematosus Study (09-122)
- Genes and Phenotype Study (09-081)
- National Lymphatic Disease and Lymphedema Registry (09-137)
- White Matter Endophenotypes in Bipolar Disorder (09-222)
- Biomarkers in the Evaluation of Chronic Lung Disease (09-076)
General Navigation
Persistent Navigation
-
Clinical Trials
- Addiction
- Aging
- Allergies
- Arthritis
- Autoimmune Disease
- Blood Disorders
- Cancer
- Children's Health
- Circulation
- Dental
- Diabetes
- Ear & Hearing
- Eyes
- Gastrointestinal/Hepatitis
- Genetics
- Heart
- HIV
- Infectious Diseases
- Joints
- Kidney
- Lung
- Lupus
- Men's Health
-
Mental Health
- Alzheimer's Disease - Endocannabinoid System Study (05.04.140)
- Alzheimer's Disease - Memantine Study (06.02.108T)
- Autism Spectrum Disorders - Adult Study (07.04.051)
- Bipolar Disorder
- Clinical Correlates of Memory Impairment (03.08.160)
- Cognitive Aging: Screening and Genetic Associations (07-127)
- Cognitive Enhancement in Bipolar Disorder (05-069)
- Dementia - Clinical Trial (08-295)
- Depression
- Ecopipam Treatment of Tourette's Disorder (PSY301, 10-02-226-03)
- Genetic Correlates of Memory Impairment (03.04.169T)
- Genetics and Dimensions of Psychopathology (09-062)
- Genetics of Early Onset Psychiatric Disorders (06-097)
- Genetics of Psychiatric Disorders (04.04.077)
- Healthy Volunteers - Screening for Research Studies (05.04.022T)
- Induced Pluripotent Stem Cells (IPS) and Psychiatric Disorders (09-280)
- Memory Disorders Study (08-219)
- Multiple Sclerosis - Diffusion Tensor MRI Correlates of Depression (03.02.084T)
- Obsessive Compulsive Disorder
- Pitch Recognition in Autistic Spectrum Disorders (04-053)
- Psychosis - Early Detection/Prevention Study (07.04.075)
- Psychosis - PET Study (09-037)
- Schizophrenia
- Tourette Syndrome - Genetic Study (08-003)
- Neurosciences
- Recruitment Registry
- Skin
- Sleep Disorders
- Smoking
- Urinary Tract
- Weight Control
- Women's Health